THE share of private higher education institutions (HEIs) in total enrolment declined from 79 percent in 2009 to 72 percent ...

Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in collaboration with Cleveland ...

The World Bank's report underscores that Uzbekistan must reform its TVET system and align skills training with labor market ...

A growing number of states are embracing student-centered reforms that align educational opportunities with economic mobility ...

In May 2025, Praxis provided an update on the EMBOLD cohort 1 study group in SCN2A and SCN8A DEEs, showing patients in the open-label extension up to 11 months had a ~90% reduction in seizures from ...

Idaho has no plan — and no money — to remodel an education database that has never lived up to its potential. Here’s an exclusive look at what went wrong.

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence company transforming oncology drug discovery and development, today announced the public release of its AI module for ...

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Thank you for your continued support as we advance our mission to develop safe, effective, and naturally derived psychedelic therapies for people living ...

The same data inadvertently highlights something else ... Delaware only got here because a court ruled its previous reassessment and property tax model violated its own constitution. Property market ...